Supernus came out after the bell yesterday with some updated information on phase 3 trials of one of their drug candidates and looks to open lower this morning on the news. Hard to tell if this news will have a material effect on the stock going forward, but we will honor our stop near $45.00 regardless. The news may act as a brief shakeout and get rid of some week stock holders or kill the momentum of the stock for quite a while, we will find out shortly. In any event, we will follow our process. We were up around 5% on the position heading into today so we have a bit of cushion should the stock open somewhat lower this morning.